Posted by Michael Wonder on 22 Mar 2023
HTA reform gets underway – terms of reference released today
22 March 2023 - Medicines Australia acknowledges the Health Technology Assessment Review Terms of Reference – released today – and will continue to advocate for bold policy reform to speed up access to innovative medicines.
CEO of Medicines Australia – and newly appointed HTA Review Reference Committee member – Elizabeth de Somer said that the release of the terms of reference kickstarts the HTA review process which must deliver equitable, timely, safe and affordable access to innovative medicines for all Australians.
